JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120936

Triciribine, inhibitor of Akt activation

Be the first to review this product! Submit a review

|

(0 Publication)

MW 320.31 g/mol, Purity >98%. Cell-permeable tricyclic nucleoside that inhibits the phosphorylation, activation and signalling of Akt. Selective over PKC, PKA, SGK and p38 pathways. Induces cell growth arrest and apoptosis in vitro.
1 Images
Chemical Structure - Triciribine, inhibitor of Akt activation (AB120936)
  • Chemical Structure

Lab

Chemical Structure - Triciribine, inhibitor of Akt activation (AB120936)

2D chemical structure image of ab120936, Triciribine, inhibitor of Akt activation

Key facts

CAS number

35943-35-2

Purity

>98%

Form

Solid

form

Molecular weight

320.31 g/mol

Molecular formula

C<sub>1</sub><sub>3</sub>H<sub>1</sub><sub>6</sub>N<sub>6</sub>O<sub>4</sub>

Nature

Synthetic

Solubility

Soluble in DMSO to 75 mM

Soluble in ethanol to 10 mM

Biological description

Cell-permeable tricyclic nucleoside that inhibits the phosphorylation, activation and signalling of Akt. Selective over PKC, PKA, SGK and p38 pathways. Induces cell growth arrest and apoptosis in vitro.

Isomeric smiles

OC[C@H]1O[C@H](C(O)C1O)N1CC2C(N)NN(C)C3NCNC1C23

IUPAC Name

1,5-Dihydro-5-methyl-1-β-D-ribofuranosyl-1,4,5,6,8-pentaazaacenaphthylen-3-amine

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com